MX353302B - Tratamiento del dolor asociado con la dislocacion de endometrio basal. - Google Patents

Tratamiento del dolor asociado con la dislocacion de endometrio basal.

Info

Publication number
MX353302B
MX353302B MX2013007690A MX2013007690A MX353302B MX 353302 B MX353302 B MX 353302B MX 2013007690 A MX2013007690 A MX 2013007690A MX 2013007690 A MX2013007690 A MX 2013007690A MX 353302 B MX353302 B MX 353302B
Authority
MX
Mexico
Prior art keywords
dislocation
pain associated
treatment
basal endometrium
endometrium
Prior art date
Application number
MX2013007690A
Other languages
English (en)
Other versions
MX2013007690A (es
Inventor
Osterloh Ian
Loumaye Ernest
Bestel Elke
Original Assignee
Preglem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preglem Sa filed Critical Preglem Sa
Publication of MX2013007690A publication Critical patent/MX2013007690A/es
Publication of MX353302B publication Critical patent/MX353302B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere en general a las enfermedades ginecológicas y, en particular, a un método para reducir el dolor asociado con la dislocación de endometrio basal.
MX2013007690A 2010-12-30 2011-12-23 Tratamiento del dolor asociado con la dislocacion de endometrio basal. MX353302B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061457107P 2010-12-30 2010-12-30
EP10197400A EP2471537A1 (en) 2010-12-30 2010-12-30 Treatment of pain associated with dislocation of basal endometrium
PCT/IB2011/055941 WO2012090143A1 (en) 2010-12-30 2011-12-23 Treatment of pain associated with dislocation of basal endometrium

Publications (2)

Publication Number Publication Date
MX2013007690A MX2013007690A (es) 2013-12-06
MX353302B true MX353302B (es) 2018-01-08

Family

ID=43928060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007690A MX353302B (es) 2010-12-30 2011-12-23 Tratamiento del dolor asociado con la dislocacion de endometrio basal.

Country Status (20)

Country Link
US (1) US10441593B2 (es)
EP (2) EP2471537A1 (es)
JP (2) JP5991988B2 (es)
KR (1) KR101940824B1 (es)
CN (1) CN103313715A (es)
AU (1) AU2011350717B2 (es)
BR (1) BR112013016789A2 (es)
CA (1) CA2818468C (es)
CO (1) CO6821932A2 (es)
EA (1) EA024609B1 (es)
GE (1) GEP20166449B (es)
HU (1) HUE048027T2 (es)
IL (1) IL227080B (es)
MX (1) MX353302B (es)
MY (1) MY170934A (es)
NZ (1) NZ612717A (es)
SG (1) SG191360A1 (es)
UA (1) UA112173C2 (es)
WO (1) WO2012090143A1 (es)
ZA (1) ZA201304868B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1011876B1 (pt) 2009-04-29 2020-03-31 Amarin Pharma, Inc. Composições farmacêuticas estáveis compreendendo etilácido eicosapentaenoico (etil-epa) e uso das mesmas para tratar ou prevenir uma doença relacionada ao cardiovascular
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN102625847A (zh) * 2009-06-15 2012-08-01 阿马里纳制药公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法
AU2011336856A1 (en) 2010-11-29 2013-07-04 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
FR2997627B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
MA51765A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
KR20200131096A (ko) 2019-05-13 2020-11-23 박만금 휴대용 단말기 거치 겸용 휴대용 공기청정기
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
ES2212912B1 (es) 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
AU2004217988C1 (en) 2003-02-28 2010-06-03 Southwest Foundation For Biomedical Research Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
WO2005020880A2 (en) * 2003-09-03 2005-03-10 Miscon Trading S.A. Methods for the treatment of endometriosis
WO2007103510A2 (en) * 2006-03-08 2007-09-13 Danco Laboratories Llc Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders
SI3263112T1 (sl) * 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
MX2009006912A (es) * 2006-12-28 2009-08-12 Repros Therapeutics Inc Metodos y formulaciones para biodisponibilidad mejorada de antiprogestinas.
PT2148681E (pt) * 2007-04-20 2016-06-17 Preglem Sa Moduladores seletivos da progesterona no tratamento da hemorragia uterina
US8299050B2 (en) 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
FR2937862B1 (fr) 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US8426392B2 (en) * 2009-12-09 2013-04-23 Laboratoire Hra-Pharma Method for providing emergency contraception

Also Published As

Publication number Publication date
EA201390948A1 (ru) 2013-11-29
JP5991988B2 (ja) 2016-09-14
BR112013016789A2 (pt) 2016-10-11
EA024609B1 (ru) 2016-10-31
IL227080B (en) 2018-01-31
AU2011350717B2 (en) 2016-11-24
ZA201304868B (en) 2014-03-26
EP2658545B1 (en) 2019-10-23
GEP20166449B (en) 2016-03-25
CO6821932A2 (es) 2013-12-31
KR101940824B1 (ko) 2019-01-21
CA2818468C (en) 2019-11-19
MX2013007690A (es) 2013-12-06
US20130281422A1 (en) 2013-10-24
EP2658545A1 (en) 2013-11-06
AU2011350717A1 (en) 2013-06-27
NZ612717A (en) 2015-07-31
JP2014501272A (ja) 2014-01-20
JP2016175943A (ja) 2016-10-06
UA112173C2 (uk) 2016-08-10
CN103313715A (zh) 2013-09-18
MY170934A (en) 2019-09-19
SG191360A1 (en) 2013-08-30
WO2012090143A1 (en) 2012-07-05
KR20140017511A (ko) 2014-02-11
US10441593B2 (en) 2019-10-15
CA2818468A1 (en) 2012-07-05
EP2471537A1 (en) 2012-07-04
HUE048027T2 (hu) 2020-05-28

Similar Documents

Publication Publication Date Title
MY170934A (en) Treatment of pain associated with dislocation of basal endometrium
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
IL215467A0 (en) Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
MX2012000006A (es) L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel.
ZA201109449B (en) Methods and products for treatment of diseases
MX357656B (es) Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias.
MX2019004364A (es) Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo.
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
GB2490854A (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
HK1214771A1 (zh) 用於治療皮膚病的製劑
GB201018154D0 (en) Method of treatment
UA56224U (ru) Способ лазерно-хирургического удаления олигоастроцитом полушарий большого мозга с медианным распространением
UA52590U (ru) Способ хирургического удлинения полового члена
UA93416C2 (ru) Способ оценки симптомов преждевременной эякуляции
UA67357U (ru) Способ восстановления зубного ряда при малых дефектах
UA44660U (ru) Способ лечения больных системными заболеваниями соединительной ткани с преимущественным поражением кожи
UA49567U (ru) Способ лечения хронических заболеваний кишечника у больных гипертонической болезнью
UA45302U (ru) Способ оценки симптомов преждевременной эякуляции
UA58971U (ru) Способ фиксации рассеченной реберной дуги
UA53217U (en) Mask for therapy and general health improvement
UA97741C2 (ru) Способ восстановления кожных покровов при глубоких распространенных ожогах микроаутодермотрансплантатами
UA45312U (uk) Спосіб діагностики та лікування алергічних захворювань
UA59660U (ru) Способ коррекции нарушений перекисных процессов в организме
UA56675U (ru) Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии
UA51385U (ru) Станок для фиксации крупного рогатого скота

Legal Events

Date Code Title Description
FG Grant or registration